Department of Neurology, Mareşal Çakmak Military Hospital, Erzurum, Turkey.
Neurol Sci. 2011 Dec;32(6):1165-9. doi: 10.1007/s10072-011-0603-7. Epub 2011 May 10.
A few cases of airplane headache (AH) have been reported in the literature. Treatment strategies of AHs are also controversial. We followed-up five patients with AH. They were symptom-free during the daytime. Their physical, neurological, and ear-nose-throat examinations were all normal. Blood chemistries, cerebral magnetic resonance imaging, cerebral magnetic resonance imaging angiography, and paranasal sinus tomography studies of the patients were also normal. We preferred triptans because of the possible effect on the mechanism of AH. Patients were recommended to use single-dose of their drugs half an hour prior to flights. All of the patients had a good response to single dose triptan treatment and became headache-free during flights. This is the first study which puts forward the usefulness of the triptans as a safe treatment choice for airplane AH.
航空性头痛（AH）的病例在文献中有过报道。AH 的治疗策略也存在争议。我们随访了五例 AH 患者。他们白天无症状。体格检查、神经系统检查和耳鼻喉检查均正常。患者的血液化学检查、脑磁共振成像、脑磁共振血管成像和鼻窦 CT 研究也正常。我们首选曲坦类药物，因为它们可能对 AH 的发病机制有影响。我们建议患者在飞行前半小时使用单剂量药物。所有患者对单次剂量曲坦类药物治疗反应良好，在飞行过程中头痛消失。这是第一项提出曲坦类药物作为航空性头痛安全治疗选择的有用性的研究。
